References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Lohbeck&Miller(2016)Practicalsynthesisofaphthalimide-basedCereblonligandtoenablePROTACdevelopment.Bioorg.Med.Chem.Lett.265260PMID:27687673
Nanthakumaretal(2015)Dissectingfibrosis:therapeuticinsightsfromthesmall-moleculetoolbox.Nat.Rev.Drug.Discov.14693PMID:26338155
Laietal(2016)ModularPROTACdesignforthedegradationofoncogenicBCR-ABL.Angew.Chem.Int.Ed.Engl.55807PMID:26593377
Winteretal(2015)Phthalimideconjugationasastrategyforinvivotargetproteindegradation.Science.3481376PMID:25999370
Keywords:Pomalidomide,supplier,Pomalidomide,TNFa,TNFalpha,TNFα,Inhibitors,inhibits,IL-2,thalidomide,cereblon,binder,ubiquitination,antiproliferative,antiangiogenic,lymphoma,Ubiquitin,E3,Ligases,Cytokines,Antiangiogenics,Ubiquitin,E3,Ligases,TocrisBioscience